Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 50: 1450-1452, 2004; 10.1373/clinchem.2004.032714
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yilmaz, F. M.
Right arrow Articles by Yücel, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yilmaz, F. M.
Right arrow Articles by Yücel, D.
Related Collections
Right arrow General Clinical Chemistry
(Clinical Chemistry. 2004;50:1450-1452.)
© 2004 American Association for Clinical Chemistry, Inc.

Technical Briefs

Automated Turbidimetric Benzalkonium Chloride Method for Measurement of Protein in Urine and Cerebrospinal Fluid

Fatma Meriç Yilmaz, Nermin Çelebi and Dogan Yücela

Ministry of Health, Ankara Hospital, Clinical Biochemistry Laboratory, Ankara 06340, Turkey

aauthor for correspondence: fax 90-312-3621857, e-mail doyucel@yahoo.com

The first 20% of the full text of this article appears below.

Various methods have been used to measure protein in urine and cerebrospinal fluid (CSF). Urinary protein can be determined by turbidimetric assays using trichloroacetic acid (1), sulfosalicylic acid (2), or benzethonium chloride (BTC) (3)(4); the biuret assay (5)(6); or protein dye-binding assays using Coomassie Brilliant Blue (CBB) (7)(8)(9)(10)(11)(12)(13), Pyrogallol Red (PYR)-molybdate (14)(15), or Ponceau S (16). The BTC, CBB, and PYR methods can be automated. Shephard and Whiting (17) used benzalkonium chloride (BC) as a precipitating agent for the determination of protein in urine and CSF by nephelometry. In this study we developed an automated turbidimetric method using BC and compared it with conventional automated methods.

Albumin fraction V (bovine), disodium molybdate · 2 H2O, NaOH, sodium azide, sodium benzoate, potassium oxalate, and succinic acid were obtained from Merck; BTC, Coomassie Brilliant Blue G 250, EDTA, and PYR were from Sigma; BC was from Serva; and phosphoric acid was from Riedel de Haen. A commercially available PYR reagent (M-TP) and protein calibrators were obtained from Beckman Coulter. A globulin solution containing mostly IgG and IgM and no albumin was obtained from the Refik Saydam Center of Hygiene, Turkey.

We developed a new method that uses the same principle as the method of Iwata and Nishikaze (3) but with BC instead of BTC. BC is a detergent and causes protein denaturation in an alkaline medium. The NaOH/EDTA reagent (reagent 1) contained 33 mmol/L EDTA and 0.5 mol/L NaOH. The BC solution (5 g/L; reagent 2) was prepared from a 50 g/L aqueous stock solution of BC. Calibrators containing . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
F. M. Yilmaz and D. Yucel
Effect of Addition of Hemolysate on Urine and Cerebrospinal Fluid Assays for Protein
Clin. Chem., January 1, 2006; 52(1): 152 - 153.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.